Menu
GeneBe

17-41878185-T-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 1P and 1B. PP2BP4

The NM_001096.3(ACLY):c.2405A>G(p.Glu802Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000113 in 1,589,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

ACLY
NM_001096.3 missense

Scores

1
4
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.97
Variant links:
Genes affected
ACLY (HGNC:115): (ATP citrate lyase) ATP citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. The enzyme is a tetramer (relative molecular weight approximately 440,000) of apparently identical subunits. It catalyzes the formation of acetyl-CoA and oxaloacetate from citrate and CoA with a concomitant hydrolysis of ATP to ADP and phosphate. The product, acetyl-CoA, serves several important biosynthetic pathways, including lipogenesis and cholesterogenesis. In nervous tissue, ATP citrate-lyase may be involved in the biosynthesis of acetylcholine. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Dec 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PP2
Missense variant where missense usually causes diseases, ACLY
BP4
Computational evidence support a benign effect (MetaRNN=0.31745797).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ACLYNM_001096.3 linkuse as main transcriptc.2405A>G p.Glu802Gly missense_variant 22/29 ENST00000352035.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ACLYENST00000352035.7 linkuse as main transcriptc.2405A>G p.Glu802Gly missense_variant 22/291 NM_001096.3 P3P53396-1

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
152024
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000434
AC:
1
AN:
230196
Hom.:
0
AF XY:
0.00000797
AC XY:
1
AN XY:
125440
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000948
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000118
AC:
17
AN:
1437866
Hom.:
0
Cov.:
30
AF XY:
0.00000978
AC XY:
7
AN XY:
715458
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000127
Gnomad4 OTH exome
AF:
0.0000506
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
152024
Hom.:
0
Cov.:
31
AF XY:
0.0000135
AC XY:
1
AN XY:
74242
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 19, 2022The c.2405A>G (p.E802G) alteration is located in exon 22 (coding exon 21) of the ACLY gene. This alteration results from a A to G substitution at nucleotide position 2405, causing the glutamic acid (E) at amino acid position 802 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.087
T
BayesDel_noAF
Benign
-0.36
Cadd
Uncertain
24
Dann
Uncertain
1.0
DEOGEN2
Uncertain
0.74
D;D;.;.;.
Eigen
Benign
0.12
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Pathogenic
1.0
D
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.32
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L;L;.;.;.
MutationTaster
Benign
1.0
D;D;D;D;D
PrimateAI
Benign
0.40
T
PROVEAN
Uncertain
-3.4
D;.;D;D;D
REVEL
Benign
0.12
Sift
Benign
0.13
T;.;T;T;T
Sift4G
Benign
0.098
T;T;T;T;T
Polyphen
0.052
B;B;.;.;.
Vest4
0.38
MutPred
0.50
Loss of solvent accessibility (P = 0.0036);Loss of solvent accessibility (P = 0.0036);.;.;.;
MVP
0.34
MPC
0.48
ClinPred
0.89
D
GERP RS
5.7
Varity_R
0.61
gMVP
0.64

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1555626502; hg19: chr17-40034438; API